Company / Return on Assets (ROA)
SAB Biotherapeutics, Inc. Return on Assets (ROA) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-19.7%
FY2025
5-year range
-95.5% / 35.6%
FY2021-FY2025
Trend
+79.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 3 years of decline, reaching -19.7%.
Based on SEC 10-K filings.
-19.7% in FY2025 with a 3-year CAGR of +1.4%.
Improved from -22.3% to -19.7% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +1.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 79.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -19.7% | +79.3% |
| FY2024 | -95.5% | -327.5% |
| FY2023 | -22.3% | -5.7% |
| FY2022 | -21.1% | -159.4% |
| FY2021 | 35.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026